E (M) 74.eight (25.five) C-reactive protein (mg/L) 5.1 [2.0.9] GGT (IU/L) 27 [193] Total cholesterol

E (M) 74.eight (25.five) C-reactive protein (mg/L) 5.1 [2.0.9] GGT (IU/L) 27 [193] Total cholesterol (mmol/L) five.five (1.1) HDL cholesterol (mmol/L) 1.four (0.4) LDL cholesterol (mmol/L) three.four (1.0) Triglycerides (mmol/L) 1.five (0.9) CIMT (mm) 0.82 [0.67.02] PON1 (g/mL) 96 [7411] PONase (U/L) 184 [13120] AREase (kU/L) 107 [8232] FRAP (M) 677 [54527] TEAC (nM) 1279 [944654] Ox-LDL (ng/mL) 4408 [3143911] TBARS (nM) 2277 [Bcl-xL Inhibitor Purity & Documentation 1559132]Sex Men Girls 126 365 0 365 (100) 55.four (13.three) 54.3 (13.two) 27.five (7.0) 32.eight (8.0) 94.9 (14.five) 96.9 (15.7) 0.93 (0.12) 0.87 (0.12) 138 (24) 136 (27) 84 (15) 81 (13) six.two (2.five) 6.five (3.1) 6.3 (1.four) six.7 (1.7) 89.five (35.5) 69.6 (18.five) three.7 [1.five.6] 5.6 [2.two.2] 31 [246] 25 [171] 5.four (1.0) five.5 (1.1) 1.three (0.5) 1.4 (0.4) 3.four (0.9) three.four (1.0) 1.7 (1.1) 1.5 (0.eight) 0.95 [0.72.22] 0.80 [0.65.95] 88 [6905] 98 [7812] 194 [15818] 183 [12421] 91 [6504] 117 [9037] 732 [59261] 655 [53711] 1366 [1018742] 1271 [936631] 5141 [3979333] 4110 [2834484] 2042 [1527772] 2304 [1625214]Diabetes No Yes 349 142 257 (73.six) 108 (76.1) 52.5 (13.4) 59.6 (11.five) 30.6 (7.three) 33.four (9.5) 94.six (16.1) one hundred.8 (12.9) 0.88 (0.12) 0.92 (0.12) 133 (23) 144 (31) 81 (14) 84 (14) five.1 (0.7) 9.5 (3.9) 5.9 (0.four) 8.three (two.2) 75.three (20.0) 81.1 (42.eight) 5.0 [1.9.4] five.5 [2.50.2] 25 [181] 29 [230] five.five (1.1) 5.five (1.2) 1.4 (0.4) 1.3 (0.four) 3.four (0.9) 3.4 (1.0) 1.four (0.eight) 1.8 (1.0) 0.77 [0.65.93] 0.98 [0.77.15] 99 [7712] 91 [6607] 204 [16725] 156 [9682] 113 [9137] 90 [6315] 722 [58852] 614 [47132] 1423 [1077746] 1051 [681320] 3916 [2755138] 5885 [4602944] 1982 [1406672] 3152 [2380655]BMI Typical Overweight Obese 93 137 261 47 (50.5) 93 (67.9) 235 (90.0) 55.three (15.2) 53.six (13.three) 54.eight (12.6) 21.five (three.1) 27.six (1.four) 37.0 (6.7) 80.5 (17.1) 90.7 (8.4) 105.1 (11.2) 0.85 (0.19) 0.89 (0.09) 0.90 (0.ten) 133 (31) 135 (25) 136 (25) 78 (12) 81 (12) 83 (15) 5.3 (1.five) 6.6 (3.4) 6.7 (3.0) five.9 (1.0) 6.eight (two.0) 6.7 (1.6) 79.four (19.1) 75.0 (19.3) 73.7 (30.0) 3.0 [1.0.6] two.9 [1.four.6] 6.8 [3.51.1] 26 [182] 25 [183] 28 [203] five.four (1.1) 5.7 (1.1) five.four (1.0) 1.6 (0.five) 1.3 (0.four) 1.3 (0.three) 3.3 (1.1) 3.six (1.0) 3.four 0.9) 1.2 (0.eight) 1.six (0.9) 1.six (0.9) 0.85 [0.65.08] 0.80 [0.70.92] 0.82 [0.68.00] 107 [9215] 99 [7711] 91 [7108] 221 [18644] 198 [15626] 172 [10206] 118 [9647] 107 [8032] 98 [7723] 754 [64211] 725 [58352] 638 [52349] 1570 [1238882] 1366 [1153846] 1206 [879505] 3535 [2511747] 4337 [2859736] 4780 [3683216] 1546 [1046369] 2238 [1546115] 2533 [1924281]Oxidative Medicine and ERK2 Activator list Cellular LongevityFPG: fasting plasma glucose; BMI: physique mass index; BP blood pressure; GGT: gamma glutamyl transferase; HDL: higher density lipoprotein; LDL: low density lipoprotein; CIMT: carotid intima-media thickness; PON1: paraoxonase 1; PONase: paraoxonase; AREase: arylesterase; FRAP: ferric lowering capacity of plasma; TEAC: trolox equivalent antioxidant capacity; Ox-LDL: oxidized LDL; TBARS: thiobarbituric acid reactive substances.Oxidative Medicine and Cellular LongevityCarotid intima-media thickness (mm) Carotid intima-media thickness (mm) Carotid intima-media thickness (mm)two.0 1.5 1.0 0.5 0.0 40 60 80 one hundred 120 Paraoxonase (g/mL)(a)two.0 1.5 1.0 0.five 0.0 50 one hundred 150 200 250 Paraoxonase activity (U/L)(b)2.0 1.five 1.0 0.five 0.0 40 60 80 100 120 140 160 Arylesterase activity (kU/L)(c)Carotid intima-media thickness (mm)Carotid intima-media thickness (mm)2.0 1.5 1.0 0.five 0.0 400 600 800 1000 Ferric reducing antioxidant power (M/L)(d)two.0 1.five 1.0 0.5 0.0 500 1000 1500 2000 ABTS TEAC (M TE/L)(e)Carotid intima-media thickness (mm)2.0 1.five 1.0 0.5 0.0 2000 4000 6000 8000 Oxydised LDL.